Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/5/2025

Interpretation of Abnormal Blood Smear Findings

Introduction to Abnormal Findings

  • The European Society for Medical Oncology (ESMO) recognizes red cell morphology abnormalities, such as polychromasia, hypochromasia, target cells, and teardrop cells, as signs of dysplasia in myelodysplastic syndromes (MDS) 2, 4
  • Persistent platelet clumping across multiple specimens may indicate an underlying platelet disorder requiring further investigation 1

Red Cell Morphology Abnormalities

  • Polychromasia indicates the presence of young red blood cells (reticulocytes) in peripheral blood, suggesting increased erythropoiesis in response to anemia or blood loss 2, 3
  • Hypochromasia is characterized by decreased hemoglobin content in red cells, resulting in increased central pallor, and is commonly seen in iron deficiency anemia, thalassemia, and sideroblastic anemia 2, 3
  • Target cells are associated with liver disease, hemoglobinopathies, post-splenectomy states, and some membrane disorders 2, 4
  • Teardrop cells are pear-shaped red cells that may indicate bone marrow infiltrative disorders and are strongly associated with myelofibrosis, myelodysplastic syndromes, and other myeloproliferative neoplasms 2, 4

Diagnostic Significance and Next Steps

  • The combination of red cell morphology abnormalities, particularly when persistent across multiple specimens, warrants consideration of myelodysplastic syndromes (MDS) 2, 4
  • The American Heart Association, as published in Circulation, notes that patients with cyanotic heart disease may develop hypochromic red cells due to iron deficiency, which can further compromise oxygen delivery 3
  • If clinical suspicion for MDS exists, bone marrow aspiration and biopsy with cytogenetic studies should be considered, as recommended by the European Society for Medical Oncology (ESMO) 2, 4
  • Flow cytometry to evaluate platelet glycoproteins may be considered if a platelet function disorder is suspected, according to the International Society on Thrombosis and Haemostasis 5, 6